raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:556955

Pancreatic agenesis-holoprosencephaly syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Antenatal
Status
active

A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by the association of pancreatic agenesis and lobar/semilobar holoprosencephaly. Insulin-dependent diabetes mellitus and pancreatic exocrine deficiency manifest early after birth. Additional reported manifestations include intrauterine growth retardation, muscle weakness, seizures, mild intellectual disability and dysmorphic craniofacial features, and agenesis of the gallbladder.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPancreatic agenesis-holoprosencephaly syndrome
frSyndrome d'agénésie du pancréas-holoprosencéphalie
dePankreasagenesie-Holoprosenzephalie-Syndrom
esSíndrome de agenesia pancreática-holoprosencefalia
itSindrome agenesia del pancreas - oloprosencefalia
nlAgenesie van pancreas - holoprosencefalie-syndroom
ptSíndrome de agenésia pancreática-holoprosencefalia
plZespół agenezji trzustki i holoprozencefalii
csSyndrom ageneze pankreatu a holoprosencefalie
ukСиндром панкреатичної агенезії-голопрозенцефалії
zh胰腺发育不全-全前脑无裂综合征
trPankreas agenezi-holoprozensefali sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM618500NTBTvalidated
ICD-10Q87.8NTBTattributedvalidated
MONDO0034142Evalidated
UMLSC5681334Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CNOT1Disease-causing germline mutation(s) inAssessedHGNC:7877ENSG0000012510760491716q21CCR4-NOT transcription complex subunit 131006513[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families4 casesWorldwideCase(s)Validated31006513[PMID]_28525974[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_31006513[PMID]_28525974[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

23 annotations · validated 2020-06-16
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0012443Abnormality of brain morphology
HP:0011467Absent gallbladder
HP:0001274Agenesis of corpus callosum
HP:0031209Decreased lipoprotein lipase activity
HP:0001360Holoprosencephaly
HP:0410289Hypoamylasemia
HP:0001511Intrauterine growth retardation
HP:0000857Neonatal insulin-dependent diabetes mellitus
HP:0100801Pancreatic aplasia
HP:0030795Reduced C-peptide level
HP:0001518Small for gestational age
Occasional (29-5%)
HP:0010938Abnormal external nose morphology
HP:0000377Abnormal pinna morphology
HP:0009658Aplasia/Hypoplasia of the phalanges of the thumb
HP:0000218High palate
HP:0010669Hypoplasia of the zygomatic bone
HP:0000601Hypotelorism
HP:0012418Hypoxemia
HP:0000369Low-set ears
HP:0000269Prominent occiput
HP:0002507Semilobar holoprosencephaly
HP:0006315Single median maxillary incisor
HP:0000340Sloping forehead

Annotation source: 28525974[PMID]_28525974[PMID]

7

Sources for this card